Kliniske forsøg med 貧血、赤血球異常症、先天性
I alt 0 resultater
Intet fundet
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Plethora Solutions Ltd
- Foshan Sanshui District People's Hospital
- Cardiovascular Center Dedinje, Belgrade, Serbia
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Lilly PharmaceuticalCompany
- Rivierduinen, Centre for Personality disorders Jelgersma
- Eurotrials Brasil Consultores Cientificos Ltda
- Paulo Sérgio Gomes Nogueira Borges
- United States Department of Defense (DOD)
- Sudimplant SAS - Groupe TBR
- S-Biotek Holding ApS
- Korea Otsuka International Asia Arab
- Gunkang Pharmaceuticals, Inc
- Arsha Vidya Tirtha
- University of Applied Sciences Jena
- Iyad Naeem Muhammad, PhD
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Oblikue Consulting
- Julian Taylor Green
- Se den fulde liste
Medicinske tilstande
- Visuel opmærksomhedsspændvidde underskud
- Hypotermi efter anæstesi, følgevirkninger
- Grå blodpladesyndrom
- Kemoterapi-induceret neutropeni
- Forhåndsfuldførelse af direktiv
- Stadie IVB Orofaryngeal (p16-negativ) karcinom AJCC v8
- Serum Albumin Lav
- Pubertet, forsinket
- Deformitet fleksion
- Malaria, Falciparum
- Immunologisk induceret lungesygdom
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Huntington Chorea
- Vibration; Eksponering
- Recidiverende eller refraktær kronisk lymfatisk leukæmi (inklusive små lymfatiske lymfomer)
- Akut anæmi
- Blefarospasme af begge øjenlåg
- Skjoldbruskkirtel og parathyreoideakirurgi
- Testikulær teratom
- Hjernetumor, primær
- Se den fulde liste
Narkotikainterventioner
- Furmonertinib 160 mg
- Sorafenib
- Cytisin
- Rovalpituzumab tesirin
- MMV390048 120mg
- Mineralocorticoid receptor antagonist
- Bimatoprost 0,03% øjendråber
- Acalabrutinib i kombination med VR
- Rekombinant monoklonalt antistof mod human epidermal vækstfaktor-receptorinjektion (HS627)
- Celecoxib
- F520
- Pemetrexed
- Cyanoakrylat
- Oxycodon
- S-adenosyl-methionin
- Pegfilgrastim
- Standard medicinsk terapi
- Ebselen
- ABY-035 i.v.
- Vosaroxin
- Se den fulde liste
CROs by country
- Contract Research Organizations in Canada
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Guinea
- Contract Research Organizations in Iran
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Morocco
- Contract Research Organizations in Qatar
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Tunisia
- CRO list by country